Does peptide therapy work?

Peptide therapy works when the specific peptide has been tested in well-run human trials, and the evidence varies enormously from one peptide to the next. Insulin, a peptide, has treated diabetes for more than 100 years. In the STEP 1 trial, adults taking semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo. In SURMOUNT-1, the average loss with tirzepatide over 72 weeks was about 15% to 21% depending on dose, compared with about 3% on placebo. Both trials tested the brand-name drugs, not compounded versions, in adults with obesity or overweight plus a related condition who also received diet and activity counseling. Many peptides sold for recovery, anti-aging or wellness rest mostly on animal studies or small early human studies, so their benefits and safety in people are unproven. A useful answer always names the peptide, the goal and the quality of the evidence.

The FDA approves a drug only after controlled trials show it is safe and effective for a specific use. Peptides that have cleared that bar include insulin, the GLP-1 medicines semaglutide and tirzepatide, and tesamorelin, which is approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Approval comes with known risks as well as benefits: semaglutide and tirzepatide both carry a boxed warning about thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Most peptides marketed online for healing, longevity or performance have not been through that process. Their support comes largely from cell and animal studies, which often fail to carry over to people. Their benefits and safety in people are unknown, so nobody can promise a result, and the honest word for them is investigational. Our FDA-approved peptides list shows which side of the line a given peptide sits on.

Ask three questions. Has the peptide been tested in randomized trials in people, or only in animals? Did those trials measure an outcome you care about, such as weight, blood sugar or fat mass, rather than a lab marker alone? Is the product you would receive the same molecule, made to pharmaceutical standards, as the one that was studied?

Our peptide evidence grades apply that test to the peptides patients ask about most, from FDA-approved drugs down to compounds with animal data only. If weight loss is your goal, our medical weight loss program explains how GLP-1 medicines are used in practice.

Checked October 30, 2026. Labels, guidelines and coverage rules change, so confirm anything that affects your care with your clinician or pharmacist.

• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
• Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
• DailyMed - WEGOVY (semaglutide) injection and tablets prescribing information.
• DailyMed - ZEPBOUND (tirzepatide) prescribing information.
• FDA: Development and approval process for drugs.
• DailyMed - EGRIFTA SV (tesamorelin) prescribing information.

More from the Peptide Therapy FAQ: How long does peptide therapy take to work? · What happens when you stop taking peptides? · Peptide evidence grades · Peptide myths vs facts · Medical weight loss in Las Vegas

Educational information from LiveNow Longevity, not medical advice. It gives no doses and does not replace an evaluation by a licensed clinician who knows your history.